Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Sensus Healthcare, Inc. Reports 127% Revenue Increase for Third Quarter 2024

Sensus Healthcare reports significant revenue growth and profitability, driven by increased sales of SRT systems in Q3 2024.Quiver AI SummarySensus Healthcare, Inc. released revised financial results for...

SRTS : 8.78 (-1.79%)
Sensus Healthcare, Inc. Reports 127% Revenue Increase and Profitability in Q3 2024, Signs Fair Deal Agreement with Platinum Dermatology Partners | SRTS Stock News

Sensus Healthcare reports significant revenue growth, improved profitability, and a new partnership with Platinum Dermatology.Quiver AI SummarySensus Healthcare, Inc. reported significant financial growth...

SRTS : 8.78 (-1.79%)
How 2022's Biggest Healthcare Gainers Could Fare In 2023

Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023

SGFY : 30.49 (+0.07%)
SRTS : 8.78 (-1.79%)
HAE : 85.88 (+1.13%)
CVS : 56.75 (-0.14%)
Take Advantage of the Dip: 3 Top Stocks To Consider

Take advantage of the downturn in the market and consider buying these three top stocks.

$DOWI : 43,464.38 (+0.13%)
DIA : 435.78 (+0.34%)
$SPX : 5,903.08 (-0.24%)
SPY : 590.31 (-0.03%)
$IUXX : 20,540.21 (-0.61%)
QQQ : 501.60 (-0.31%)
SRTS : 8.78 (-1.79%)
INSW : 41.26 (-1.46%)
GLNG : 35.84 (-0.39%)
IHI : 60.07 (+0.20%)
Take Advantage of the Dip: 3 Top Stocks To Consider

The market has taken a significant downturn this week. Traders and investors can take advantage of this move by looking for stocks that are expected to thrive in the near-term.

$DOWI : 43,464.38 (+0.13%)
DIA : 435.78 (+0.34%)
$SPX : 5,903.08 (-0.24%)
SPY : 590.31 (-0.03%)
$IUXX : 20,540.21 (-0.61%)
QQQ : 501.60 (-0.31%)
SRTS : 8.78 (-1.79%)
INSW : 41.26 (-1.46%)
GLNG : 35.84 (-0.39%)
IHI : 60.07 (+0.20%)
Sensus Healthcare Launches Upgrade to its SRT-100 Vision System with New State-of-the-Art Ultrasound Capabilities

Includes a new ergonomic probe to operate in ideal MHz range to view all layers of skin...

SRTS : 8.78 (-1.79%)
Sensus Healthcare Takes Order for 10 TransDermal Infusion Systems™ Supporting Hair Enhancement Centers Expansion Along with U.SK Under Skin’s Hair-Health Serum

BOCA RATON, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,...

SRTS : 8.78 (-1.79%)
Sensus Healthcare to Host Second Quarter 2022 Financial Results and Business Update Conference Call on August 4, 2022

BOCA RATON, Fla., July 26, 2022 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,...

SRTS : 8.78 (-1.79%)
Colorado State University College of Veterinary Medicine and Biomedical Sciences Acquires Second SRT System from Sensus Healthcare

Researchers at the Johnson Family Equine Hospital to study superficial radiation therapy in horses following the University’s successful use in companion...

SRTS : 8.78 (-1.79%)
Correction: Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference

BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,...

SRTS : 8.78 (-1.79%)

Barchart Exclusives

Wall Street Has a 'Buy' Rating For These 2 Growth Stocks After Earnings
Both of these growth stocks are recovering well. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar